NE
Roles
Therapeutic Areas
Prelude Therapeutics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| PRT3789 | SMARCA4-mutant cancers | Phase 1/2 |
| PRT2527 | Hematologic malignancies and solid tumors | Phase 1/2 |
| PRT3645 | Cancers dependent on CDK4/6 | Phase 1 |
| PRT543/PRT811 | MTAP-deleted cancers | Phase 1 |
| PRT13722 | ER+ breast cancer and other solid tumors | Preclinical |
| PRT12396 | Myeloproliferative neoplasms (JAK2V617F) | IND Cleared |
| Precision DACs | Undisclosed solid tumors | Discovery |